350 related articles for article (PubMed ID: 28619049)
1. Non-inferiority versus superiority drug claims: the (not so) subtle distinction.
Ganju J; Rom D
Trials; 2017 Jun; 18(1):278. PubMed ID: 28619049
[TBL] [Abstract][Full Text] [Related]
2. Superiority and non-inferiority: two sides of the same coin?
Dunn DT; Copas AJ; Brocklehurst P
Trials; 2018 Sep; 19(1):499. PubMed ID: 30223881
[TBL] [Abstract][Full Text] [Related]
3. Optimal Use of the Non-Inferiority Trial Design.
Angeli F; Verdecchia P; Vaudo G; Masnaghetti S; Reboldi G
Pharmaceut Med; 2020 Jun; 34(3):159-165. PubMed ID: 32277352
[TBL] [Abstract][Full Text] [Related]
4. Handling an uncertain control group event risk in non-inferiority trials: non-inferiority frontiers and the power-stabilising transformation.
Quartagno M; Walker AS; Babiker AG; Turner RM; Parmar MKB; Copas A; White IR
Trials; 2020 Feb; 21(1):145. PubMed ID: 32029000
[TBL] [Abstract][Full Text] [Related]
5. Testing superiority and non-inferiority hypotheses in active controlled clinical trials.
Tsong Y; Zhang JJ
Biom J; 2005 Feb; 47(1):62-74; discussion 99-107. PubMed ID: 16395997
[TBL] [Abstract][Full Text] [Related]
6. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
Hirotsu C
Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
[TBL] [Abstract][Full Text] [Related]
7. Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review.
Althunian TA; de Boer A; Klungel OH; Insani WN; Groenwold RH
Trials; 2017 Mar; 18(1):107. PubMed ID: 28270184
[TBL] [Abstract][Full Text] [Related]
8. Non-inferiority study design: lessons to be learned from cardiovascular trials.
Head SJ; Kaul S; Bogers AJ; Kappetein AP
Eur Heart J; 2012 Jun; 33(11):1318-24. PubMed ID: 22564354
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk associated with celecoxib or etoricoxib: a meta-analysis of randomized controlled trials which adopted comparison with placebo or naproxen.
De Vecchis R; Baldi C; Di Biase G; Ariano C; Cioppa C; Giasi A; Valente L; Cantatrione S
Minerva Cardioangiol; 2014 Dec; 62(6):437-48. PubMed ID: 25029569
[TBL] [Abstract][Full Text] [Related]
10. Non-inferiority trials in cardiology: what clinicians need to know.
Leung JT; Barnes SL; Lo ST; Leung DY
Heart; 2020 Jan; 106(2):99-104. PubMed ID: 31672779
[TBL] [Abstract][Full Text] [Related]
11. Methodological aspects of superiority, equivalence, and non-inferiority trials.
Stefanos R; Graziella D'; Giovanni T
Intern Emerg Med; 2020 Sep; 15(6):1085-1091. PubMed ID: 32705494
[TBL] [Abstract][Full Text] [Related]
12. Equivalence concepts in clinical trials.
Steinijans VW; Neuhäuser M; Bretz F
Eur J Drug Metab Pharmacokinet; 2000; 25(1):38-40. PubMed ID: 11032089
[TBL] [Abstract][Full Text] [Related]
13. Methodological standards in non-inferiority AIDS trials: moving from adherence to compliance.
Parienti JJ; Verdon R; Massari V
BMC Med Res Methodol; 2006 Sep; 6():46. PubMed ID: 16987409
[TBL] [Abstract][Full Text] [Related]
14. Multiple comparisons in non-inferiority trials: Reaction to recent regulatory guidance on multiple endpoints in clinical trials.
Wiens BL
J Biopharm Stat; 2018; 28(1):52-62. PubMed ID: 29065276
[TBL] [Abstract][Full Text] [Related]
15. A regulatory perspective on choice of margin and statistical inference issue in non-inferiority trials.
Hung HM; Wang SJ; O'Neill R
Biom J; 2005 Feb; 47(1):28-36; discussion 99-107. PubMed ID: 16395994
[TBL] [Abstract][Full Text] [Related]
16. Testing superiority at interim analyses in a non-inferiority trial.
Chen YH; Chen C
Stat Med; 2012 Jul; 31(15):1531-42. PubMed ID: 22438208
[TBL] [Abstract][Full Text] [Related]
17. [Non-inferiority and equivalence trials: Key methodological issues].
Herr M; Descatha A; Aegerter P
Rev Med Interne; 2018 May; 39(5):352-359. PubMed ID: 28693836
[TBL] [Abstract][Full Text] [Related]
18. On non-inferiority margin and statistical tests in active control trials.
Chow SC; Shao J
Stat Med; 2006 Apr; 25(7):1101-13. PubMed ID: 16345042
[TBL] [Abstract][Full Text] [Related]
19. Bayes factors for superiority, non-inferiority, and equivalence designs.
van Ravenzwaaij D; Monden R; Tendeiro JN; Ioannidis JPA
BMC Med Res Methodol; 2019 Mar; 19(1):71. PubMed ID: 30925900
[TBL] [Abstract][Full Text] [Related]
20. NSAIDs and serious cardiovascular disorders: especially cox-2 inhibitors and diclofenac.
Prescrire Int; 2016 Jan; 25(167):14-6. PubMed ID: 26942254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
